HCA Healthcare Inc (NYSE:HCA) insider Michael S. Cuffe sold 2,400 shares of the business’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $86.63, for a total transaction of $207,912.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
HCA Healthcare Inc (NYSE:HCA) traded up $2.01 during trading on Thursday, hitting $86.97. 1,911,085 shares of the stock were exchanged, compared to its average volume of 2,114,998. The company has a quick ratio of 1.41, a current ratio of 1.68 and a debt-to-equity ratio of -6.46. The stock has a market cap of $31,270.00, a P/E ratio of 12.37, a price-to-earnings-growth ratio of 1.17 and a beta of 0.55. HCA Healthcare Inc has a twelve month low of $71.18 and a twelve month high of $91.03.
HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.21. The firm had revenue of $10.70 billion during the quarter, compared to analysts’ expectations of $10.70 billion. HCA Healthcare had a net margin of 6.13% and a negative return on equity of 47.16%. The business’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.45 earnings per share. equities research analysts forecast that HCA Healthcare Inc will post 6.56 earnings per share for the current year.
A number of equities analysts recently weighed in on HCA shares. KeyCorp restated an “overweight” rating and set a $90.00 price target (down from $95.00) on shares of HCA Healthcare in a research report on Thursday, October 19th. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 price target on the stock. in a research report on Wednesday, December 20th. Citigroup upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating in a research report on Tuesday, December 12th. Cantor Fitzgerald restated a “buy” rating and set a $90.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 31st. Finally, Zacks Investment Research lowered shares of HCA Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, October 17th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $87.80.
Hedge funds have recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. grew its holdings in shares of HCA Healthcare by 14.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after purchasing an additional 143 shares in the last quarter. Bronfman E.L. Rothschild L.P. grew its holdings in shares of HCA Healthcare by 35.1% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after purchasing an additional 320 shares in the last quarter. Atlantic Trust LLC acquired a new position in shares of HCA Healthcare in the second quarter valued at approximately $118,000. Acrospire Investment Management LLC grew its holdings in shares of HCA Healthcare by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after purchasing an additional 200 shares in the last quarter. Finally, BB&T Investment Services Inc. acquired a new position in shares of HCA Healthcare in the second quarter valued at approximately $141,000. Hedge funds and other institutional investors own 75.34% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “HCA Healthcare Inc (HCA) Insider Michael S. Cuffe Sells 2,400 Shares” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/11/hca-healthcare-inc-hca-insider-michael-s-cuffe-sells-2400-shares-of-stock.html.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.